HK Stock MarketDetailed Quotes

01093 CSPC PHARMA

Watchlist
  • 5.070
  • +0.020+0.40%
Market Closed Nov 29 16:08 CST
59.30BMarket Cap10.37P/E (TTM)

CSPC PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CSPC PHARMA FY2024 9-Month Earnings Date

Currency：CNYNov 15, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
22.69B
--
-4.94%
EPS
--
0.32
--
-15.33%
Analyst Rating
Strong Buy

Nov 29, 2024

CSPC PHARMA Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: HKD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.942B--
--2024/Q4-- / 7.749B--
Nov 15, 20242024/Q36.887B / 8.015B--
--2024/Q27.974B / 9.154B--
Aug 21, 20242024/Q19.690B / 8.073B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.942B--
--2024/Q4-- / 7.749B--
Nov 15, 20242024/Q36.887B / 8.015B--
--2024/Q27.974B / 9.154B--
Aug 21, 20242024/Q19.690B / 8.073B--

Unlock Free Earnings Estimates

CSPC PHARMA Earnings Reports

  • CSPC PHARMA: QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024

    Nov 14 23:01 ET

  • CSPC PHARMA: DATE OF BOARD MEETING

    Nov 5 05:02 ET

  • CSPC PHARMA: PROFIT WARNING

    Oct 31 05:53 ET

  • CSPC PHARMA: UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024

    Oct 23 06:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 29, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      0.00%

    • Hold

      20.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg

    No Data